Left Ventricular Assist Device Performance With Long-Term Circulatory Support: Lessons From the REMATCH Trial Walter P. Dembitsky, MD, Alfred J. Tector,

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Trevor Williams, MD, MPH, Brian C

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality Nader Moazami, MD, Carmelo A. Milano,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Defining high-risk patients for endovascular aneurysm repair

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Dhaval Chauhan, MD, Alexis K

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations Giovanni Filardo, PhD, MPH, Paul.

Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation Li Zhang, MD, MS,

Sharven Taghavi, MD, MPH, Charisse Ward, MD, Senthil N

Reoperation After Mitral Valve Repair for Degenerative Disease

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Javed Butler, MD, Carrie Geisberg, MD, Renee Howser, MSN, Peer M

Bahaaldin Alsoufi, MD, Sally Cai, PhD, Glen S

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Trevor Williams, MD, MPH, Brian C

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Surgical Resection of Rare Esophageal Cancers

Ventricular assist device programs: design and function

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Comparative Effects of Ventricular Assist Device and Extracorporeal Membrane Oxygenation on Renal Function in Pediatric Heart Failure Parthak Prodhan,

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

William L. Holman, MD, James K. Kirklin, MD, David C

John F. Lazar, MD, Michael F. Swartz, PhD, Matthew P

Characteristics of Malignant Pleural Mesothelioma in Women

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Editorial Board, January 2010

Patient and Surgical Factors Influencing Air Leak After Lung Volume Reduction Surgery: Lessons Learned From the National Emphysema Treatment Trial Malcolm.

Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Correction of Tetralogy of Fallot and of Pulmonary Atresia with Ventricular Septal Defect in Adults Jürgen Hörer, MD, Julia Friebe, MD, Christian Schreiber,

Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation Justin M. Schaffer, MS, George J. Arnaoutakis,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Kiyotaka Fukamachi, MD, PhD, Patrick.

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Early and Midterm Outcomes for Tricuspid Valve Surgery After Left-Sided Valve Surgery Choung Kyu Park, MD, Pyo Won Park, MD, Kiick Sung, MD, Young Tak.

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Annetine C. Gelijns, PhD, Alexandra F. Richards, BS, Deborah L

Influence of Prosthesis–Patient Mismatch on Diastolic Heart Failure After Aortic Valve Replacement Shahab Nozohoor, MD, Johan Nilsson, MD, PhD, Carsten.

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Stephen Greer, MD, Ashley D. Miller, FNP, Jeremiah S

Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation Kathleen L Grady, PhD, RN, Peter M Meyer,

Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome Eva Maria B. Delmo Walter, MD, PhD, Richard Van.

Presentation transcript:

Left Ventricular Assist Device Performance With Long-Term Circulatory Support: Lessons From the REMATCH Trial Walter P. Dembitsky, MD, Alfred J. Tector, MD, Soon Park, MD, Alan J. Moskowitz, MD, Annetine C. Gelijns, PhD, Nuala S. Ronan, RN, William Piccione, MD, William L. Holman, MD, Satoshi Furukawa, MD, Alan D. Weinberg, MS, Gerald Heatley, MS, Victor L. Poirier, MBA, Laura Damme, RN, MPH, James W. Long, MD The Annals of Thoracic Surgery Volume 78, Issue 6, Pages 2123-2130 (December 2004) DOI: 10.1016/j.athoracsur.2004.02.030

Fig 1 Freedom from left ventricular assist device (LVAD) failure. This product-limit estimate curve plots the probability of being free of device failure versus time (days) and includes the six device failure events that occurred during the prespecified 24-visit follow-up period. Patients were censored (circles) when they died or when, at the last date of follow-up, they had not experienced a device failure. The Annals of Thoracic Surgery 2004 78, 2123-2130DOI: (10.1016/j.athoracsur.2004.02.030)

Fig 2 Freedom from left ventricular assist device replacement. This product-limit estimate curve plots the probability of being free of device replacement versus time (days). Patients were censored (circles) when they died or when, at the last date of follow-up, they had not undergone a device replacement. The Annals of Thoracic Surgery 2004 78, 2123-2130DOI: (10.1016/j.athoracsur.2004.02.030)

Fig 3 Survival postoperative left ventricular assist device replacement. This product-limit estimate curve plots the probability of survival after device replacement. Circles depict patients who are alive. The Annals of Thoracic Surgery 2004 78, 2123-2130DOI: (10.1016/j.athoracsur.2004.02.030)

Fig 4 Survival postoperative left ventricular assist device replacement stratified by the presence of sepsis. This product-limit estimate curve plots the probability of survival after device replacement stratified by the cause of device failure (sepsis related replacement versus all other causes). Circles depict patients who are alive. The Annals of Thoracic Surgery 2004 78, 2123-2130DOI: (10.1016/j.athoracsur.2004.02.030)